<!--
✒ Metadata
    - Title: CRISPR and Beyond Works Cited (Knowledge Nexus 2026 Edition - v1.0)
    - File Name: crispr_and_beyond_works_cited.md
    - Relative Path: articles\04-life-sciences\crispr-and-beyond\crispr_and_beyond_works_cited.md
    - Artifact Type: docs
    - Version: 1.0.0
    - Date: 2026-01-03
    - Update: Friday, January 03, 2026
    - Author: Dennis 'dnoice' Smaltz
    - A.I. Acknowledgement: Google Deep Mind - Gemini 3 Pro
    - Signature: ︻デ═─── ✦ ✦ ✦ | Aim Twice, Shoot Once!

✒ Description:
    Comprehensive bibliography matrix documenting all sources referenced in the
    CRISPR and Beyond deep-dive article. Organized by topic category with full
    citation information, publication dates, and access details.

✒ Key Features:
    - Feature 1: Categorized source organization by technology domain
    - Feature 2: Publication date tracking for currency verification
    - Feature 3: Direct URLs for source verification
    - Feature 4: Source type classification (academic, industry, news)
    - Feature 5: Key data points extracted from each source

✒ Usage Instructions:
    Cross-reference with crispr_and_beyond.md for fact verification.
    URLs current as of research date; verify accessibility before citation.
    Primary sources prioritized where available.

✒ Other Important Information:
    - Dependencies: Companion to crispr_and_beyond.md
    - Research date: January 2026
    - Source verification: All sources accessed via web search
---------
-->

# CRISPR and Beyond: Works Cited

## Clinical Trials and FDA Approvals

### FDA-Approved Therapies

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease | FDA | Casgevy and Lyfgenia approval, first CRISPR therapy | Dec 2023 |
| Revolutionary breakthrough: FDA approves CASGEVY | PMC | Comprehensive analysis of approval significance | 2024 |
| First CRISPR Therapy Approved for Sickle Cell | Columbia University Irving Medical Center | Clinical context and impact | Dec 2023 |
| World's First CRISPR-Based Gene Therapy Approved by FDA | New York Stem Cell Foundation | Therapeutic mechanism details | Dec 2023 |
| FDA Approves First CRISPR Gene Editing Treatment | Scientific American | 29/30 participants pain-free results | Dec 2023 |

### Clinical Trial Landscape

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| CRISPR Clinical Trials: A 2025 Update | Innovative Genomics Institute | 250 trials monitored, 150+ active | Feb 2025 |
| CRISPR Clinical Trials: A 2024 Update | Innovative Genomics Institute | UC consortium trial, manufacturing challenges | 2024 |
| Overview CRISPR Clinical Trials 2025 | CRISPR Medicine News | Comprehensive trial database | 2025 |
| Advancing CRISPR genome editing into gene therapy clinical trials | PMC | Progress and future prospects analysis | 2025 |

## Base Editing and Prime Editing

### David Liu and Breakthrough Advances

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| David Liu Wins 2025 Breakthrough Prize | The Scientist | Recognition for base and prime editing | Sep 2024 |
| David Liu Awarded Breakthrough Prize | HHMI | Ceremony details, Alyssa Tapley appearance | Apr 2025 |
| Single prime editing system could potentially treat multiple genetic diseases | Broad Institute | PERT technology announcement | Nov 2025 |
| Prime editing-installed suppressor tRNAs for disease-agnostic genome editing | Nature | Technical details of PERT system | Nov 2025 |
| Improved prime editing system makes gene-sized edits in human cells | Broad Institute | Therapeutic-level editing efficiency | 2025 |

### Prime Editing Clinical Applications

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Prime editing corrects a childhood genetic disease in mice | C&EN | AHC correction, 43-90% efficiency | Jul 2025 |
| Prime Editing Corrects Genetic Mutations Causing Rare Childhood Brain Disease | HHMI | ATP1A3 mutations, AAV9 delivery | Jul 2025 |
| Emerging trends in prime editing for precision genome editing | Nature Experimental & Molecular Medicine | Technical review and applications | 2025 |
| Q&A: David Liu's bold vision | Broad Institute | Personalized therapy development, K.J. Muldoon case | May 2025 |

### Base Editing Clinical Progress

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| CRISPR 2.0 Breakthroughs: Gene Editing in 2025 | NewsVault | 12 participants, June 2025 dosing, 59% LDL reduction | 2025 |
| Best Genomics Stories of 2025 | The Scientist | Year in review, major advances | Dec 2025 |
| CRISPR Gene Editing in 2025: Breakthroughs, Jobs & Research Opportunities | BioTecNika | Industry landscape overview | 2025 |

## Cas Protein Mechanisms

### Cas9, Cas12, and Cas13 Comparison

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| A Review on the Mechanism and Applications of CRISPR/Cas9/Cas12/Cas13/Cas14 | PMC | Comprehensive mechanism review | Sep 2022 |
| CRISPR-Cas12: A Versatile Tool for Genome Editing | University of Kansas | Cas12 specific applications | 2024 |
| CRISPR 101: Cas9 vs. The Other Cas(s) | Addgene | Educational comparison of Cas variants | Accessed 2026 |
| New frontiers in CRISPR: Addressing antimicrobial resistance | PubMed | Cas9, Cas12, Cas13, Cas14 for AMR | Jan 2025 |
| Unleashing the potential of CRISPR multiplexing | ScienceDirect | Cas12 and Cas13 for eye diseases | 2023 |

### Diagnostic Applications

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| CRISPR-driven diagnostics: Molecular mechanisms, clinical efficacy | PMC | aM-level detection sensitivity | 2025 |
| Assessing and advancing the safety of CRISPR-Cas tools | Nature Communications | DNA to RNA editing safety assessment | Jan 2023 |

## Off-Target Effects and Safety

### Detection Methods

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Beyond the promise: evaluating and mitigating off-target effects | Frontiers in Bioengineering | Comprehensive safety evaluation | 2023 |
| Off-target effects in CRISPR-Cas genome editing for human therapeutics | ScienceDirect | Progress and challenges review | 2025 |
| Guarding the genome: strategies for off-target detection | Expert Review of Molecular Diagnostics | Detection and minimization strategies | 2025 |
| Off-target effects in CRISPR/Cas9 gene editing | PMC | Mechanism analysis | Mar 2023 |
| CRISPRoffT: comprehensive database | Nucleic Acids Research | Database of off-target effects | 2025 |

### Mitigation Strategies

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Computational Prediction of Off-Target Effects | Bioscience Publisher | AI and deep learning approaches | 2025 |
| CRISPR Off-Target Effects: Mechanisms and Solutions | Danaher Life Sciences | Industry perspective on solutions | Accessed 2026 |
| CRISPR Off-Target Editing: Prediction, Analysis, and More | Synthego | Practical guidance for researchers | Accessed 2026 |
| CRISPR-Cas9 Off-Target Effects: Challenges and Solutions | AZO Life Sciences | Overview of challenges | Accessed 2026 |

## Delivery Methods

### Lipid Nanoparticles

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 | UPenn Mitchell Lab (ACS Nano) | 16-37% lung editing efficiency | Apr 2025 |
| Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Components | Molecular Pharmaceutics | Formulation strategies | 2022 |
| Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components | Small Methods (Wiley) | Comprehensive review | 2024 |
| Lipid Nanoparticles for CFTR Integration | bioRxiv | Mutation-agnostic disease rescue | Jan 2025 |
| Lung and liver editing by LNP delivery of stable CRISPR-Cas9 RNP | Nature Biotechnology | Tissue-selective formulations | 2024 |

### Comparative Studies

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Electroporation and Lipid Nanoparticles as Delivery Methods | ElevateBio | 4-fold more viable edited T cells with LNP | May 2025 |
| Advances in Nanoparticles as Non-Viral Vectors | PMC | Non-viral delivery review | Sep 2024 |
| CRISPR/CAS9 And Gene Editing in Drug Delivery | Impact Factor Journal | Drug delivery applications | 2025 |

## Epigenome Editing

### CRISPRa, CRISPRi, and CRISPRoff

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| CRISPR-Based Epigenome Editing: Mechanisms and Applications | Taylor & Francis | Comprehensive epigenome editing review | 2024 |
| Programmable epigenome editing by transient delivery | Nature Communications | RENDER platform for RNP delivery | 2025 |
| Targeted Epigenome Editing with CRISPR Technologies | Medtigo Journal | Cancer treatment strategies | 2025 |
| CRISPRoff epigenome editing for programmable gene silencing | PMC | Human cell lines and primary T cells | Apr 2025 |
| Bidirectional epigenetic editing reveals hierarchies | Nature Biotechnology | CRISPRai system development | May 2024 |

### Advanced Applications

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| CRISPR GENome and epigenome engineering improves genetic-screening | PMC | CRISPRgenee system | 2025 |
| CRISPR Tools for T cells: Targeting Genome, Epigenome, Transcriptome | PMC | T cell therapy applications | 2025 |

## Agricultural Applications

### Crop Engineering

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Revolutionizing Agriculture With CRISPR Technology | Biotechnology Journal (Wiley) | Applications, challenges, perspectives | 2025 |
| Genome editing in future crop protection | Discover Agriculture (Springer) | Disease, pest, weed resistance | 2024 |
| An insight into the journey of CRISPR-CAS9 in crop improvement | Discover Plants (Springer) | Historical and current applications | 2025 |
| Application of CRISPR in Plant Improvement: An Update Review | Advances in Agriculture (Wiley) | Recent developments | 2025 |
| Recent advances of CRISPR-based genome editing for enhancing staple crops | Frontiers in Plant Science | Staple crop improvements | 2024 |

### Climate and Disease Resistance

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Engineering crops of the future: CRISPR approaches | Genome Biology | Climate-resilient and disease-resistant plants | 2020 |
| CRISPR/Cas9: a sustainable technology to enhance climate resilience | Frontiers in Genome Editing | Climate adaptation strategies | 2025 |
| CRISPR Agriculture News Today: 7 Powerful Advances in 2025 | Farmonaut | Cassava viral resistance breakthrough | 2025 |
| Applications of CRISPR in Crop Improvement and Global Food Security | IntechOpen | Food security applications | 2024 |

## Cancer and Therapeutic Applications

| Source | Author/Publisher | Key Data | Date |
| ------ | ---------------- | -------- | ---- |
| Gene editing in cancer therapy: overcoming drug resistance | Cancer Gene Therapy (Nature) | Precision medicine applications | 2025 |
| Recent Advancements in CRISPR-Cas9 Technology for Precision Gene Editing | Journal of Neonatal Surgery | Therapeutic applications review | 2025 |
| Successful Gene Editing Demonstrated for Rare Neurodevelopmental Disorder | Northwestern Feinberg News | Clinical success story | Aug 2025 |

## Reference URLs

### FDA and Regulatory

- <https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease>
- <https://pmc.ncbi.nlm.nih.gov/articles/PMC11305803/>
- <https://www.cuimc.columbia.edu/news/columbia-impact-first-new-crispr-therapy-approved-sickle-cell>
- <https://nyscf.org/resources/worlds-first-crispr-based-gene-therapy-approved-by-fda/>

### Clinical Trials

- <https://innovativegenomics.org/news/crispr-clinical-trials-2025/>
- <https://innovativegenomics.org/news/crispr-clinical-trials-2024/>
- <https://crisprmedicinenews.com/clinical-trials/>
- <https://pmc.ncbi.nlm.nih.gov/articles/PMC12094669/>

### Prime Editing and Base Editing

- <https://www.broadinstitute.org/news/single-prime-editing-system-could-potentially-treat-multiple-genetic-diseases>
- <https://www.the-scientist.com/david-liu-wins-2025-breakthrough-prize-for-base-editing-and-prime-editing-72888>
- <https://www.hhmi.org/news/david-liu-awarded-breakthrough-prize>
- <https://www.nature.com/articles/s41586-025-09732-2>
- <https://www.nature.com/articles/s12276-025-01463-8>

### Cas Protein Mechanisms

- <https://pmc.ncbi.nlm.nih.gov/articles/PMC9512960/>
- <https://journals.ku.edu/sjm/article/download/23277/20976/80781>
- <https://blog.addgene.org/crispr-101-cas9-vs.-the-other-cass>
- <https://pubmed.ncbi.nlm.nih.gov/39906792/>

### Off-Target Effects

- <https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2023.1339189/full>
- <https://www.sciencedirect.com/science/article/pii/S2162253125001908>
- <https://www.tandfonline.com/doi/full/10.1080/14737159.2025.2581677>
- <https://academic.oup.com/nar/advance-article-pdf/doi/10.1093/nar/gkae1025/60586532/gkae1025.pdf>

### Delivery Methods

- <https://mitchell-lab.seas.upenn.edu/wp-content/uploads/2025/04/Haley_ACSNano.pdf>
- <https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.1c00916>
- <https://onlinelibrary.wiley.com/doi/10.1002/smtd.202401632>
- <https://www.nature.com/articles/s41587-024-02437-3>
- <https://elevate.bio/wp-content/uploads/2025/05/Electroporation-and-Lipid-Nanoparticles-as-Delivery-Methods-for-Targeted-CRISPR-Cas9-Gene-Editing-in-Primary-Human-T-Cells_Final.pdf>

### Epigenome Editing

- <https://www.tandfonline.com/doi/full/10.2217/epi-2023-0281>
- <https://www.nature.com/articles/s41467-025-63167-x>
- <https://pmc.ncbi.nlm.nih.gov/articles/PMC12052198/>
- <https://www.nature.com/articles/s41587-024-02213-3>

### Agriculture

- <https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/biot.70113>
- <https://link.springer.com/article/10.1007/s44279-024-00124-0>
- <https://link.springer.com/article/10.1007/s44372-025-00343-9>
- <https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2024.1478398/full>
- <https://farmonaut.com/news/crispr-agriculture-news-today-7-powerful-advances-in-2025>

---

> **︻デ═─── ✦ ✦ ✦ | Aim Twice, Shoot Once!**

